Advertisement
The Journal of Heart and Lung Transplantation
International Society for Heart and Lung Transplantation.

Posterior reversible encephalopathy syndrome (PRES) after pediatric heart transplantation: A multi-institutional cohort

Published:September 25, 2022DOI:https://doi.org/10.1016/j.healun.2022.09.014

      Background

      PRES is a relatively rare complication of heart transplantation (HTx), and its clinical course and risk factors remain poorly understood. We sought to examine the incidence, natural history, and risk factors for PRES after pediatric HTx.

      Methods

      Fourteen-center retrospective study of 42 PRES-cases and 1,502 HTx-recipients without PRES, between 2000 and 2018. Demographic and clinical data were collected into a central database. Factors associated with PRES were identified by Cox Proportional Hazard multivariable analysis.

      Results

      PRES occurred in 3.2% of HTx-recipients > 1 year of age; no infants developed PRES. Median onset of symptoms was 16 days (R 2-2468 days) after HTx, most commonly seizures (38/42) or altered mental status (24/42). Almost all recipients (40/42) recovered fully. MRI showed typical vasogenic edema in 33/39. Those with PRES had gradually worsening hypertension in the preceding 5 days, culminating in severely elevated blood pressure (>P99+5 mm Hg) for 34 recipients when presenting with PRES. Calcineurin inhibitor (CNI) levels were supratherapeutic in only 8/42, and CNI-management did not significantly impact outcome. Risk of PRES was 12.8x higher in those with pretransplant Glenn/Fontan (CI 1.69, 96.27; p = .013) compared to recipients with congenital heart disease without Glenn/Fontan, while sex, age, BMI or ischemic time did not contribute significantly.

      Conclusions

      Pediatric PRES generally occurs early after HTx, with seizures as the most common presenting symptom. Most patients are severely hypertensive upon presentation, whereas only 19% have supratherapeutic CNI-levels. Pre-existing Glenn or Fontan physiology is a strong risk factor for PRES after HTx. Almost all recipients recovered fully within days of presentation.

      KEYWORDS

      Abbreviations:

      PRES (Posterior reversible encephalopathy syndrome), MRI (Magnetic resonance imaging), CNI (Calcineurin inhibitor), HTx (Heart transplant), BMI (Body mass index), CHD (Congenital heart disease), TAC (Tacrolimus), CSA (Cyclosporine-A), CVP (Central Venous Pressure)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Heart and Lung Transplantation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hinchey J
        • Chaves C
        • Appigniani B
        • et al.
        A reversible posterior leukoencephalopathy syndrome.
        New England J Med. 1996; 334: 494-500
        • Chen TH
        • Chiou SS
        • Lin WC
        • et al.
        Posterior reversible encephalopathy syndrome in critically ill children: a case series.
        Intensive Care Med. 2013; 39: 155-156
        • Wu Q
        • Marescaux C
        • Wolff V
        • et al.
        Tacrolimus-associated posterior reversible encephalopathy syndrome after solid organ transplantation.
        Eur Neurol. 2010; 64: 169-177
        • Cruz RJ
        • DiMartini A
        • Akhavanheidari M
        • et al.
        Posterior reversible encephalopathy syndrome in liver transplant patients: clinical presentation, risk factors and initial management.
        Am J Transplantation. 2012; 12: 2228-2236
        • Santos MM
        • Tannuri AC
        • Gibelli NE
        • et al.
        Posterior reversible encephalopathy syndrome after liver transplantation in children: a rare complication related to calcineurin inhibitor effects.
        Pediatr Transplant. 2011; 15: 157-160
        • Ishikura K
        • Hamasaki Y
        • Sakai T
        • Hataya H
        • Mak RH
        • Honda M.
        Posterior reversible encephalopathy syndrome in children with kidney diseases.
        Pediat Nephrol. 2012; 27: 375-384
        • Bartynski WS
        • Tan HP
        • Boardman JF
        • Shapiro R
        • Marsh JW.
        Posterior reversible encephalopathy syndrome after solid organ transplantation.
        Am J Neuroradiol. 2008; 29: 924-930
        • Bartynski WS.
        Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features.
        Am J Neurorad. 2008; 29: 1036-1042
        • Hefzy HM
        • Bartynski WS
        • Boardman JF
        • Lacomis D.
        Hemorrhage in posterior reversible encephalopathy syndrome: imaging and clinical features.
        Am J Neurorad. 2009; 30: 1371-1379
        • Schwartz RB
        • Bravo SB
        • Klufas RA
        • et al.
        Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases.
        Am J Roentgenology. 1995; 165: 627-631
        • Thompson CB
        • June CH
        • Sullivan KM
        • et al.
        Association between cyclosporine neurotoxicity and hypomagnesaemia.
        Lancet. 1984; 2: 1116-1120
        • Bartynski WS.
        Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema.
        Am J Neuroradiol. 2008; 29: 1043-1049
        • Araz C
        • Camkiran A
        • Zeyneloglu P
        • et al.
        Early-onset posterior reversible encephalopathy syndrome after solid organ transplantation in pediatric patients: a report of 2 cases.
        Transplant Proc. 2013; 45: 3555-3557
        • Loar RW
        • Patterson MC
        • O'Leary PW
        • Driscoll DJ
        • Johnson JN
        Posterior reversible encephalopathy syndrome and hemorrhage associated with tacrolimus in pediatric heart transplant recipient.
        Pediatr Transpl. 2013; 17: E67-E70
        • Torocsik H
        • Curless R
        • Post J
        • Yzakis A
        • Pearse L.
        FK506-induced leukoencephalopathy in children with organ transplants.
        Neurology. 1999; 52: 1497-1500
        • Eilers B
        • Albers E
        • Law Y
        • et al.
        Posterior reversible encephalopathy syndrome after pediatric heart transplantation: increased risk for children with preexisting Glenn/Fontan physiology.
        Pediatric Transpl. 2016; 20: 552-558
        • Bartynski WS
        • Boardman JF.
        Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome.
        Am J Neuroradiology. 2007; 28: 1320-1327
        • Ishikura K
        • Ikeda M
        • Hamasaki Y
        • et al.
        Posterior reversible encephalopathy syndrome in children: its high prevalence and more extensive imaging findings.
        Am J Kidney Dis. 2006; 48: 231-238
        • Bechstein WO.
        Neurotoxicity of calcineurin inhibitors:impact and clinical management.
        Transpl Int. 2000; 13: 313-326
        • Giacinto O
        • Satriano U
        • Nenna A
        • et al.
        Inflammatory response and endothelial dysfunction following cardiopulmonary bypass: pathophysiology and pharmacological targets.
        Recent Patents on Inflammation and Allergy Drug Discovery. 2019; 13: 158-173
        • Lin ZB
        • Ci HB
        • Li Y
        • et al.
        Endothelial microparticles are increased in congenital heart diseases and contribute to endothelial dysfunction.
        J Translational Med. 2017; 15: 4
        • Scicchitano P
        • Gesualdo M
        • Cortese F
        • et al.
        Atrial septal defect and patent foramen ovale: early and long-term effects on endothelial function after percutaneous occlusion procedure.
        Heart and Vessels. 2019; 34: 1499-1508
        • Oechslin E
        • Kiowski W
        • Schindler R
        • et al.
        Systemic endothelial dysfunction in adults with cyanotic congenital heart disease.
        Circulation. 2005; 112: 1106-1112
        • Mahle W
        • Todd K
        • Fyfe D.
        Endothelial function following Fontan operation.
        Am J Cardiol. 2003; 91: 1286-1288
        • Jin SM
        • Noh CI
        • Bae EJ
        • Choi JY
        • Yun YS.
        Impaired vascular function in patients with Fontan circulation.
        Int J Cardiol. 2007; 120: 221-226
        • Binotto MA.
        • Maeda NY
        • Lopes AA.
        Altered endothelial function following the Fontan procedure.
        Cardiol Young. 2008; 18: 70-74
        • Lee MGY
        • Hemmes RA
        • Mynard J
        • et al.
        Elevated sympathetic activity, endothelial dysfunction, and late hypertension after repair of coarctation of the aorta.
        Internat J Cardiol. 2017; 243: 185-190
        • Vita JA
        • Treasure CB
        • Yeung AC
        • et al.
        Patients with evidence of coronary endothelial dysfunction assessed by acetylcholine infusion demonstrate marked increase in sensitivity to constrictor effects of catecholamines.
        Circulation. 1992; 85: 1390-1397
        • Furchgott RF
        Role of endothelium in responses of vascular smooth muscle.
        Circ Res. 1983; 53: 557-573
        • Toda N
        • Nakanishi-Toda M.
        How mental stress affects endothelial function.
        Eur J Physiol. 2011; 462: 779-794
        • Horbinksi C
        • Bartynski WS
        • Cardon-Walter E
        • Hamilton RL
        • Tan HP
        • Cheng S.
        Reversible encephalopathy after cardiac transplantation: histologic evidence of endothelial activation, T-cell specific trafficking, and vascular endothelial growth factor expression. Case Report.
        Am J Neuroradiol. 2009; 30: 588-590
        • Marra A
        • Vargas M
        • Striano P
        • DelGuercio L
        • Buonanno P
        • Servillo G.
        Posterior reversible encephalopathy syndrome: the endothelial hypotheses.
        Med Hypotheses. 2014; 82: 619-622
        • Schwartz RB.
        Hyperperfusion encephalopathies: Hypertensive encephalopathy and related conditions.
        Neurologist. 2002; 8: 22-34
        • Ogren JA
        • Fonarow GC
        • Woo MA.
        Cerebral impairment in heart failure.
        Curr Heart Fail Rep. 2014; 11: 321-329
        • Paulson OB
        • Strandgaard S
        • Edvinsson L.
        Cerebral autoregulation.
        Cerebrovasc Brain Metab Rev. 1990; 2: 161-192
        • Bouma GJ
        • Muizelaar JP.
        Relationship between cardiac output and cerebral blood flow in patients with intact and with impaired autoregulation.
        J Neurosurg. 1990; 73: 368-374
        • Vaughan CJ
        • Delanty N.
        Hypertensive emergencies.
        Lancet. 2000; 356: 411-417
        • Loar RW
        • Patterson MC
        • O'Leary PW
        • et al.
        Posterior reversible encephalopathy syndrome and hemorrhage associated with tacrolimus in a pediatric heart transplantation recipient.
        Transplantation. 2013; 17: E67-E70